Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 4:12:6807-6819.
doi: 10.2147/CMAR.S240000. eCollection 2020.

LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p

Xinying Shen  1 , Yong Li  1 , Fan He  1 , Jian Kong  1
Affiliations

LncRNA CDKN2B-AS1 Promotes Cell Viability, Migration, and Invasion of Hepatocellular Carcinoma via Sponging miR-424-5p

Xinying Shen et al. Cancer Manag Res. .

Abstract

Objective: Hepatocellular carcinoma (HCC) results in high mortality and metastasis. In this study, the effects of long non-coding RNA (lncRNA) CDKN2B-AS1 on the progression of HCC were investigated.

Materials and methods: LncRNA CDKN2B-AS1 expression of HCC cancer and adjacent tissues, and HCC cells were detected. Subsequently, CDKN2B-AS1 was overexpressed and silenced in HCC cells to observe the effects of CDKN2B-AS1 on the cell viability, migration, invasion, and epithelial-mesenchymal transition (EMT) of HCC cells by performing cell counting kit-8 (CCK-8), wound-healing, Transwell, and Western blot. The target gene of CDKN2B-AS1 was predicted and verified to be miR-424-5p, whose expression in HCC cells with up- or down-regulation of CDKN2B-AS1 expression was determined. Moreover, the effects of miR-424-5p on cell viability, migration, and invasion and EMT of HCC cells were investigated with miR-424-5p up-regulation or down-regulation, together with overexpression or silencing of CDKN2B-AS1.

Results: CDKN2B-AS1 expression was increased in HCC tissues and cells. Silencing of CDKN2B-AS1 suppressed cell viability, migration, invasion, and EMT, while overexpression of CDKN2B-AS1 produced the opposite results. Furthermore, CDKN2B-AS1 was predicted and verified to target miR-424-5p and was confirmed to negatively modulate miR-424-5p expression. Moreover, overexpression of miR-424-5p partially suppressed the previously high cell viability, migration, and invasion, and activated EMT resulted from up-regulation of CDKN2B-AS1, while silencing of miR-424-5p elevated the cellular processes inhibited by silencing the expression of CDKN2B-AS1.

Conclusion: The present study revealed that high-expressed CDKN2B-AS1 may associate with the progression of HCC by affecting the cell viability, migration, invasion, and EMT of HCC cells by negatively regulating miR-424-5p.

Keywords: hepatocellular carcinoma; invasion; lncRNA CDKN2B-AS1; miR-424-5p; migration.

PubMed Disclaimer

Conflict of interest statement

The athors declare no conflicts of interest.

Figures

Figure 1
Figure 1
CDKN2B-AS1 expression in HCC tissues and cells was detected by qRT-PCR. (A) The expression level of CDKN2B-AS1 in HCC and its adjacent tissues (n=30). **P<0.001, vs. Normal. (B) The expression level of CDKN2B-AS1 in THLE-2, Huh7, Hep3B, MHCC97H and Sk-Hep1 cells. **P<0.001, vs. THLE-2.
Figure 2
Figure 2
Transection efficiency and cell viability in Huh7 cells transfected with siCDKN2B-AS1 and MHCC97H cells transfected with CDKN2B-AS1, with the group divided into blank, siNC, siCDKN2B-AS1 or blank, NC, CDKN2B-AS1. (A, B) CDKN2B-AS1 expression in Huh7 and MHCC97H cells was determined by qRT-PCR, GAPDH was used as internal reference. (C, D) Cell viability in Huh7 and MHCC97H cells was determined by CC-8 assay. *P<0.05, **P<0.001, vs. Blank. #P<0.05, ##P<0.001, vs. siNC or NC.
Figure 3
Figure 3
Cell migration and invasion capacities in Huh7 cells transfected with siCDKN2B-AS1 and MHCC97H cells transfected with CDKN2B-AS1, with the group divided into blank, siNC, siCDKN2B-AS1 or blank, NC, CDKN2B-AS1. (A–D) Determination of cell migration ability by wound-healing assay. (E–H) Determination of cell invasion ability by transwell assay. **P<0.001, vs. Blank. ##P<0.001, vs. siNC or NC.
Figure 4
Figure 4
EMT related protein expression in Huh7 cells transfected with siCDKN2B-AS1 and MHCC97H cells transfected with CDKN2B-AS1, with the group divided into blank, siNC, siCDKN2B-AS1 or blank, NC, CDKN2B-AS1, GAPDH was used as internal reference. (A, B) Determination of E-Cadherin, N-Cadherin and Snail expression in Huh7 cells transfected with siCDKN2B-AS1 by Western blot. (C, D) Determination of E-Cadherin, N-Cadherin and Snail expression in MHCC97H cells transfected with CDKN2B-AS1 by Western blot. *P<0.05, **P<0.001, vs. Blank. #P<0.05, ##P<0.001, vs. siNC or NC.
Figure 5
Figure 5
MiR-424-5p was the target gene of CDKN2B-AS1 and its expression in Huh7 cells transfected with siCDKN2B-AS1 and MHCC97H cells transfected with CDKN2B-AS1, with the group divided into blank, siNC, siCDKN2B-AS1 or blank, NC, CDKN2B-AS1. (A) The target gene of CDKN2B-AS1 was predicted by starBase. (B, C) The verification of CDKN2B-AS1 targeting miR-424-5p by dual-luciferase assay in Huh7 and MHCC97H cells. (D) The expression level of miR-424-5p in HCC and its adjacent tissues (n=30). (E) The correlations between CDKN2B-AS1 and miR-424-5p expression in HCC tissues. (F, G) The expression of miR-424-5p was measured by qRT-PCR, the internal reference was U6. **P<0.001, vs. Normal or Blank. ##P<0.001, vs. siNC or NC.
Figure 6
Figure 6
Transection efficiency and cell viability in Huh7 cells and MHCC97H cells, with the group divided into MC, M, IC, I and siCDKN2B-AS1+I in Huh7 cells or MC, M, IC, I and CDKN2B-AS1+M in MHCC97H cells. (A, B) miR-424-5p expression in Huh7 and MHCC97H cells was determined by qRT-PCR, U6 was used as internal reference. (C, D) Cell viability in Huh7 and MHCC97H cells was determined by CCK-8 assay. **P<0.001, vs. MC. ##P<0.001, vs. IC. ^^P<0.001, vs. I or M.
Figure 7
Figure 7
Cell migration and invasion capacities in Huh7 cells and MHCC97H cells, with the group divided into MC, M, IC, I and siCDKN2B-AS1+I in Huh7 cells or MC, M, IC, I and CDKN2B-AS1+M in MHCC97H cells. (A–D) The migration ability of Huh7 and MHCC97H cells was determined by wound-healing assay. (E–H) The invasion ability of Huh 7 and MHCC97H cells was determined by transwell assay. **P<0.001, vs. MC. ##P<0.001, vs. IC. ^^P<0.001, vs. I or M.
Figure 8
Figure 8
EMT related protein expression in Huh7 cells and MHCC97H cells, with the group divided into MC, M, IC, I and siCDKN2B-AS1+I in Huh7 cells or MC, M, IC, I and CDKN2B-AS1+M in MHCC97H cells. GAPDH was used as internal reference. (A, B) Determination of E-Cadherin, N-Cadherin and Snail expression in Huh7 cells by Western blot. (C, D) Determination of E-Cadherin, N-Cadherin and Snail expression in MHCC97H cells by Western blot. **P<0.001, vs. MC. ##P<0.001, vs. IC. ^^P<0.001, vs. I or M.
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66. doi: 10.3322/canjclin.57.1.43 - DOI - PubMed
    1. Desai JR, Ochoa S, Prins PA, He AR. Systemic therapy for advanced hepatocellular carcinoma: an update. J Gastrointest Oncol. 2017;8(2):243–255. doi: 10.21037/jgo.2017.02.01 - DOI - PMC - PubMed
    1. Tang ZY, Ye SL, Liu YK, et al. A decade’s studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130(4):187–196. doi: 10.1007/s00432-003-0511-1 - DOI - PMC - PubMed
    1. Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981. doi: 10.1158/0008-5472.CAN-16-2634 - DOI - PMC - PubMed
    1. Soudyab M, Iranpour M, Ghafouri-Fard S. The role of long non-coding RNAs in breast cancer. Arch Iran Med. 2016;19(7):508–517. - PubMed